Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal)

  • Technology appraisal
  • TA435
  • Published: 
Download guidance (PDF)

Advice

NICE is unable to make a recommendation about the use in the NHS of tenofovir alafenamide for treating chronic hepatitis B because no evidence submission was received from Gilead for the technology.